Par Settlement Gets OK In Zetia Generic Delay Case
A Virginia magistrate judge has recommended approval of a settlement between several drug purchasers and Par Pharmaceuticals in a case alleging the company, along with Merck & Co. Inc. and Glenmark...To view the full article, register now.
Already a subscriber? Click here to view full article